[Federal Register Volume 59, Number 102 (Friday, May 27, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-12971]
[[Page Unknown]]
[Federal Register: May 27, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Heart, Lung, and Blood Institute; Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
Heart, Lung, and Blood Special Emphasis Panel (SEP) meetings:
Name of SEP: Evaluation of Physician Attitudes and Practices
Regarding Cholesterol and Coronary Heart Disease.
Date: June 13-14, 1994.
Time: 7:30 p.m.
Place: Holiday Inn, Bethesda, Maryland.
Contact Person: Dr. Anthony M. Coelho, Jr., Scientific Review
Administrator, 5333 Westbard Avenue, room 648, Bethesda, Maryland
20892 (301) 594-7485.
Purpose/Agenda: To review and evaluate contract proposals.
Name of SEP: Hematologic Consequences of HIV Infection of Marrow
Cells.
Date: June 29-30, 1994.
Time: 8 p.m.
Place: Holiday Inn, Bethesda, Maryland.
Contact Person: Dr. S. Charles Selden, Scientist Review
Administrator, 5333 Westbard Avenue, room 552B, Bethesda, Maryland
20892 (301) 594-7477.
Purpose/Agenda: To evaluate and review grant applications.
These meetings will be closed in accordance with the provisions set
forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart
and Vascular Diseases Research; 93.838, Lung Diseases Research; and
93.839, Blood Diseases and Resources Research, National Institutes
of Health.)
Dated: May 20, 1994.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 94-12971 Filed 5-26-94; 8:45 am]
BILLING CODE 4140-01-M
